Clicky

Black Diamond Therapeutics, Inc.(BDTX)

Description: Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies for cancer treatment. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various early stage pipeline programs of allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.


Keywords: Biotechnology Cancer Diamond Cancer Treatment Enzymes Tyrosine Kinase Receptors Epidermal Growth Factor Receptor Genetic Diseases Oncogenes Therapies For Cancer Kinase Rare Genetic Diseases Protein Kinase Rare Genetic Disease Black Diamond Gefitinib Icotinib

Home Page: www.blackdiamondtherapeutics.com

BDTX Technical Analysis

One Main Street
Cambridge, MA 02142
United States
Phone: 617 252 0848


Officers

Name Title
Dr. David M. Epstein Ph.D. Co-Founder, Pres, CEO & Director
Dr. Fang Ni Pharm.D. CFO, Principal Financial Officer and Chief Bus. Officer
Mr. Brent Hatzis-Schoch Esq., J.D. COO & Gen. Counsel
Dr. Elizabeth Buck Ph.D. Co-Founder & Chief Scientific Officer
Ms. Erika Jones VP of Fin., Corp. Controller & Principal Accounting Officer
Ms. Elizabeth L. Montgomery Chief People Officer
Dr. Christopher D. Roberts Ph.D. Advisor
Mr. Tai-An Lin Ph.D. Sr. VP of Translational Science & Discovery Biology
Dr. Sergey Yurasov M.D., Ph.D. Chief Medical Officer
Ms. Melanie Morrison Sr. VP of Devel. Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.404
Price-to-Sales TTM: 0
IPO Date: 2020-01-30
Fiscal Year End: December
Full Time Employees: 86
Back to stocks